Bibliographic details
Roustit M, Blaise S, Allanore Y, Carpentier PH, Caglayan E, Cracowski JL. Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Annals of the Rheumatic Diseases 2013; 72(10): 1696-1699
MeSH
Carbolines /therapeutic use; Humans; Imidazoles /therapeutic use; Phosphodiesterase 5 Inhibitors /therapeutic use; Piperazines /therapeutic use; Purines /therapeutic use; Randomized Controlled Trials as Topic; Raynaud Disease /drug therapy; Sildenafil Citrate; Sulfones /therapeutic use; Tadalafil; Treatment Outcome; Triazines /therapeutic use; Vardenafil Dihydrochloride